Krystal Biotech, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares
Krystal Biotech, Inc. (KRYS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares of 133.69 thousand shares for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-04.
Discontinued › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares · last filed 2019-11-04
- Krystal Biotech, Inc. share-based compensation arrangement by share-based payment award, options, vested, number of shares for the quarter ending 2019-09-30 was -18.05K shares, a 265.30% decline year-over-year.
- Krystal Biotech, Inc. share-based compensation arrangement by share-based payment award, options, vested, number of shares for the quarter ending 2019-06-30 was 39.38K shares, a 111.78% increase year-over-year.
- Krystal Biotech, Inc. share-based compensation arrangement by share-based payment award, options, vested, number of shares for the quarter ending 2019-03-31 was 112.36K shares, a 216.31% increase year-over-year.
- Krystal Biotech, Inc. share-based compensation arrangement by share-based payment award, options, vested, number of shares for the quarter ending 2018-09-30 was 10.92K shares.
- Krystal Biotech, Inc. share-based compensation arrangement by share-based payment award, options, vested, number of shares for fiscal 2017 was 43.22K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares 12 month |
|---|---|---|---|---|
| 2019-09-30 | -18.05K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | 21.33K shares derived: sum of 2 quarters · filed 2019-11-04 | 133.69K shares 10-Q · filed 2019-11-04 | |
| 2019-06-30 | 39.38K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | 151.74K shares 10-Q · filed 2019-08-05 | ||
| 2019-03-31 | 112.36K shares 10-Q · filed 2019-05-07 | |||
| 2018-09-30 | 10.92K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | 29.52K shares derived: sum of 2 quarters · filed 2018-11-05 | 65.04K shares 10-Q · filed 2018-11-05 | -18.84M shares derived: sum of 4 quarters · filed 2018-11-05 |
| 2018-06-30 | 18.59K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | 54.12K shares 10-Q · filed 2018-08-06 | -18.85M shares derived: sum of 3 quarters · filed 2018-08-06 | |
| 2018-03-31 | 35.52K shares 10-Q · filed 2018-05-07 | -18.87M shares derived: sum of 2 quarters · filed 2018-05-07 | ||
| 2017-12-31 | -18.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | 43.22K shares 10-K · filed 2018-03-12 | ||
| 2017-09-30 | 18.95M shares 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |